Luca Laurenti

12.3k total citations
220 papers, 4.8k citations indexed

About

Luca Laurenti is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Luca Laurenti has authored 220 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 135 papers in Genetics, 76 papers in Pathology and Forensic Medicine and 74 papers in Hematology. Recurrent topics in Luca Laurenti's work include Chronic Lymphocytic Leukemia Research (125 papers), Lymphoma Diagnosis and Treatment (72 papers) and Immunodeficiency and Autoimmune Disorders (39 papers). Luca Laurenti is often cited by papers focused on Chronic Lymphocytic Leukemia Research (125 papers), Lymphoma Diagnosis and Treatment (72 papers) and Immunodeficiency and Autoimmune Disorders (39 papers). Luca Laurenti collaborates with scholars based in Italy, United States and Japan. Luca Laurenti's co-authors include Dimitar G. Efremov, Giuseppe Leone, Simona Sica, Stefania Gobessi, Pablo G. Longo, Patrizia Chiusolo, Giovanni D’Arena, Federica Sorà, Silvia Deaglio and Gianluca Gaïdano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Luca Laurenti

210 papers receiving 4.7k citations

Peers

Luca Laurenti

GENET

IMMUN

PFM

HEMAT

Giovanni Del Poeta Italy

Sergej Konoplev United States

Thierry Lamy France

Gerassimos A. Pangalis Greece

Anders Österborg Sweden

Javier Pinilla‐Ibarz United States

Kazimierz Kuliczkowski Poland

Steven H. Bernstein United States

Alexander Egle Austria

Dina Ben‐Yehuda Israel

Giovanni Del Poeta Italy

Luca Laurenti

2.2k ×0.9

GENET

1.4k ×0.8

IMMUN

1.5k ×1.1

PFM

1.6k ×1.2

2.7k ×2.4

HEMAT

Citations per year, relative to Luca Laurenti Luca Laurenti (= 1×) peers Giovanni Del Poeta

Countries citing papers authored by Luca Laurenti

Since Specialization

Citations

This map shows the geographic impact of Luca Laurenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Laurenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Laurenti more than expected).

Fields of papers citing papers by Luca Laurenti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Laurenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Laurenti. The network helps show where Luca Laurenti may publish in the future.

Co-authorship network of co-authors of Luca Laurenti

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Laurenti. A scholar is included among the top collaborators of Luca Laurenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Laurenti. Luca Laurenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laurenti, Luca, et al.. (2025). Piecewise Control Barrier Functions for Stochastic Systems. 3571–3576. 1 indexed citations

D’Arena, Giovanni, Candida Vitale, Giuseppe Pietrantuono, et al.. (2024). What Does Atypical Chronic Lymphocytic Leukemia Really Mean? A Retrospective Morphological and Immunophenotypic Study. Cancers. 16(2). 469–469. 3 indexed citations

Innocenti, Idanna, et al.. (2024). Treatment Sequencing in Chronic Lymphocytic Leukemia in 2024: Where We Are and Where We Are Headed. Cancers. 16(11). 2011–2011. 2 indexed citations

Duong, Trinh, Michael Li, Andres Ferbér, et al.. (2024). Real-world safety profile of therapy with ibrutinib or acalabrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. SHILAP Revista de lepidopterología. 2(1). 100064–100064. 1 indexed citations

Francesco, Alessandra Di, Anna Maria Raiola, Alida Dominietto, et al.. (2024). Acute graft versus host disease 1976–2020: reduced incidence and predictive factors. Frontiers in Medicine. 10. 1320692–1320692. 4 indexed citations

Sharman, Jeff P., Luca Laurenti, Emmanuelle Ferrant, et al.. (2024). CRISTALLO: Results from a Phase III Trial of Venetoclax-Obinutuzumab Versus Fludarabine, Cyclophosphamide and Rituximab or Bendamustine-Rituximab in Patients with Untreated Chronic Lymphocytic Leukemia without Del(17p) or TP53 Mutations. Blood. 144(Supplement 1). 3237–3237.

Innocenti, Idanna, Eugenio Galli, Patrizia Chiusolo, et al.. (2023). Prevention of CINV in Patients with Multiple Myeloma or Lymphoma Undergoing Hematopoietic Stem Cell Transplantation: NEPA Versus Ondansetron. a Monocentric Real-Life Experience. Blood. 142(Supplement 1). 7067–7067.

Innocenti, Idanna, Michela Tarnani, Eugenio Galli, et al.. (2023). Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience. Cancers. 15(23). 5592–5592. 2 indexed citations

Galli, Eugenio, Elisabetta Metafuni, Sabrina Giammarco, et al.. (2022). Triple post transplant cyclophosphamide (PTCY) based GVHD prophylaxis: HLA matched versus HLA haploidentical transplants. Bone Marrow Transplantation. 57(4). 532–537. 8 indexed citations

10.

Autore, Francesco, et al.. (2021). Treatment Options for Elderly/Unfit Patients with Chronic Lymphocytic Leukemia in the Era of Targeted Drugs: A Comprehensive Review. Journal of Clinical Medicine. 10(21). 5104–5104. 6 indexed citations

11.

Molica, Stefano, Luca Laurenti, Paolo Ghia, et al.. (2021). COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study). Blood. 138(Supplement 1). 4690–4690. 1 indexed citations

12.

Vervloessem, Tamara, Binu K. Sasi, Spyridoula Karamanou, et al.. (2020). BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models. Cell Death and Disease. 11(9). 769–769. 20 indexed citations

13.

Sabatelli, Mario, Luca Laurenti, & Marco Luigetti. (2018). PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS. Mediterranean Journal of Hematology and Infectious Diseases. 10. e2018057–e2018057. 1 indexed citations

14.

Laurenti, Luca. (2013). THE USE OF MONOCLONAL ANTIBODIES IN THE TREATMENT OF AUTOIMMUNE COMPLICATIONS OF CHRONIC LYMPHOCYTIC LEUKEMIA. Mediterranean Journal of Hematology and Infectious Diseases. 5(1). e2013027–e2013027. 3 indexed citations

15.

Efremov, Dimitar G., Adrian Wiestner, & Luca Laurenti. (2012). NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL. Mediterranean Journal of Hematology and Infectious Diseases. 4(1). e2012067–e2012067. 13 indexed citations

16.

Audrito, Valentina, Tiziana Vaisitti, Davide Rossi, et al.. (2011). Nicotinamide Blocks Proliferation and Induces Apoptosis of Chronic Lymphocytic Leukemia Cells through Activation of the p53/miR-34a/SIRT1 Tumor Suppressor Network. Cancer Research. 71(13). 4473–4483. 138 indexed citations

17.

Palladino, Mariangela, Luca Laurenti, Patrizia Chiusolo, et al.. (2010). Low-Dose Valganciclovir as Preemptive Therapy for Cytomegalovirus Infection Occurring in Allogeneic Stem Cell Transplant Recipients. Acta Haematologica. 123(4). 230–234. 9 indexed citations

18.

Laurenti, Luca, et al.. (2010). Reduced expression of the tumor suppressor PHLPP1 enhances the antiapoptotic B-cell receptor signal in chronic lymphocytic leukemia B-cells. Leukemia. 24(12). 2063–2071. 23 indexed citations

19.

Chiusolo, Patrizia, Giovanni Reddiconto, Giuliana Farina, et al.. (2007). MTHFR polymorphisms’ influence on outcome and toxicity in acute lymphoblastic leukemia patients. Leukemia Research. 31(12). 1669–1674. 51 indexed citations

20.

Sica, Simona, Patrizia Chiusolo, Prassede Salutari, et al.. (2000). Autologous Graft-Versus-Host Disease after CD34+-Purified Autologous Peripheral Blood Progenitor Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 9(3). 375–379. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact